Herpes simplex virus type-2 in Egyptian patients with bladder cancer or cystitis

APMIS

Volumn 118, Issue 1, 2010, Pages 37-44

  Badawi, Hala ^a   Ahmed, Hanem ^b   Aboul Fadl, Laila ^a   Helmi, Amira ^b   Fam, Nevine ^a   Diab, Manal ^a   Ismail, Ahmed ^b   Badawi, Afkar ^a   Saber, Mohamed ^b  

^a Theodor Bilharz Research Institute   (Egypt)

^b Department of Biochemistry ^*  (Egypt)

Author keywords

Bladder cancer; Cystitis; Herpes simplex virus type 2 (HSV 2)

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN G 2; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER; BLADDER BIOPSY; BLADDER CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTITIS; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SCHISTOSOMIASIS; SENSITIVITY AND SPECIFICITY; VIRUS LIKE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; BIOPSY; CYSTITIS; DNA, VIRAL; EGYPT; FEMALE; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; POLYMERASE CHAIN REACTION; SEROEPIDEMIOLOGIC STUDIES; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 73149113317     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2009.02556.x     Document Type: Article

References (31)

1. Zarzour AH, Selim M, Abd- El Sayed AA, Hameed DA, Abdelaziz MA. Muscle invasive bladder cancer in Upper Egypt. The shift in risk factors and tumour characteristics. BMC Cancer 2008 8 : 250.
2. Gazzaniga P, Vercillo R, Gradilone A, Silvestri I, Gandini D, Napolitano M, et al. Prevalence of papillomavirus, Epstein-Barr virus, cytomegalovirus, and herpes simplex virus type 2 in urinary bladder cancer. J Med Virol 1998 55 : 262 7.
3. Jamalidiloost M, Soleimanjahi H, Fatouhi F, Meshkatz Z. Amplification and cloning of herpes simplex virus type 2 glycoprotein G from an Iranian isolate. Pak J Biol Sci 2007 10 : 955 8.
4. Marsden HS, Mac Aulay K, Murvay J, Smith W. Identification of an immunodominant sequential epitope in glycoprotein G of herpes simplex virus type 2 that is useful for serotype-specific diagnosis. J Med Virol 1998 56 : 79 84.
5. Balachandran N, Hutt-Fletcher LM. Synthesis and processing of glycoprotein gG of herpes simplex virus type 2. J Virol 1985 54 : 825 32.
6. Sobin LH. The WHO histological classification of urinary bladder tumours. Urol Res 1978 6 : 193 5.
7. Flemming I, Cooper J, Henson D, Hutter R, Kennedy BJ. Urinary bladder. In : Femming ID, editor. American Joint Committee on Cancer: AJCC Cancer Staging Manual, 5th edn. Philadelphia : Lippincott-Raven Publishers, 1997 : 241 6.
8. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968 97 : 77 89.
9. Ausubel MF, Brent R, Kingston RE, Moore D, Seidman GJ, Smith AJ, et al. Current Protocols in Molecular Biology. New York : Wiley Intersciences, 1990 : 1 22.
10. Higushi R. Simple and rapid preparation of samples for PCR. In : Erlich HA, editor. PCR Technology. Principles and Applications for DNA Amplification. New York : Stockton Press, 1989 : 31 8.
11. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, Vol. I, Chapter 6. New York : Cold Spring Harbor Press, 1989 : 3.
12. Grimaud JA, Druget M, Peyrol S, Chevalier O, Herbage D, El Badrawy N. Collagen immunotyping in human liver. Light and electron microscopic study. J Histochem Cytol 1980 28 : 1145 51.
13. Abol-Enein H. Infection: is it a cause of bladder cancer? Scand J Urol Nephrol 2008 42 : 79 84.
14. El-Bolkainy MN. Topographic Pathology of Cancer, Vol. 7, 2nd edn. Cairo : Al Ahram Press, 2000 : 57 64.
15. Hay S, Kannourakis G. A time to kill: viral manipulation of the cell death program. J Gen Virol 2002 83 : 1547 64.
16. Hasan R. The viral roots of cancer. J Young Investig 2002 5.
17. Le Blanc JJ, Campbell S, Pettipas J, Hatchette TF, Davidson RJ. Herpes simplex virus type 2 displays atypical melting temperature profiles at low viral titers. J Clin Microbiol 2008 46 : 2786 9.
18. Abrahan AM, Babu M, Kartha S, Kavitha S, Jesudason MV, Sridharan G. A molecular method for typing herpes simplex virus isolates as an alternative to immunofluorescence methods. Indian J Med Microbiol 2009 27 : 22 6.
19. Corey L, Huang ML, Selkes S, Wald A. Differentiation between herpes simplex virus type 1 and 2 in clinical samples by a real-time taqman PCR assay. J Med Virol 2005 76 : 350 5.
20. Ashley RL, Wu L, Pickering JW, Tu MC, Schnorenberg L. Premarket evaluation of a commercial glycoprotein G based enzyme immunoassay for herpes simplex type-specific antibodies. J Clin Microbiol 1998 36 : 294 5.
21. Groen J, Van Dijk G, Niesters HG, Van Der Meijden WI, Osterhaus AD. Comparison of two enzyme-linked immunosorbent assays and one rapid immunoblot assay for detection of herpes simplex virus type-2 specific antibodies in serum. J Clin Microbiol 1998 36 : 845 7.
22. Eis-Hübinger AM, Daumer M, Matz B, Schneweisk E. Evaluation of three glycoprotein G-2 based enzyme immunoassays for detection of antibodies to herpes simplex virus type 2 in human sera. J Clin Microbiol 1999 37 : 1242 6.
23. Ohana B, Lipson M, Vered N, Srug I, Ahdut M, Morag A. Novel approach for specific detection of herpes simplex virus type 1 and 2 antibodies and immunoglobulin G and M antibodies. Clin Diagn Lab Immunol 2000 7 : 904 8.
24. Benharroshi J, Dauphin H, Porcheret H, Meritet JF, Boulanger MC, Maisonneuve L. Comparison of two ELISA tests to study the seroprevalence of herpes simplex 1 and 2 infection in a maternity near paris. Ann Biol Clin 2008 66 : 665 70.
25. Görander S, Svennerholm B, Liljeqvist JA. Secretory portion of glycoprotein G of herpes simplex virus type 2 is a novel antigen for type-discriminating serology. J Clin Microbiol 2003 41 : 3681 6.
26. Kasubi MJ, Nilsen A, Marsden HS, Bergstrom T, Langeland N, Haarr L. A branched, synthetic oligopeptide corresponding to a region of glycoprotein G of HSV-2 reacts sensitively and specifically with HSV-2 antibodies in an ELISA. J Virol Methods 2005 125 : 137 43.
27. Heintzman J, Rugge B, Judkin DZ, Julka M. Clinical inquiries. What's the best for HSV-2 after exposure? J Fam Pract 2007 56 : 221 2.
28. Eing BR, Lippelt L, Lorentzen EU, Hafezi W, Schlumberger W, Steinhagen K. Evaluation of confirmatory strategies for detection of type specific antibodies against herpes simplex virus type 2. J Clin Microbiol 2002 40 : 407 13.
29. Ngo TD, Laeyendecker O, Morrow RA, Lai S, Quinn TC. Comparison of three commercial immunoassays for detection of herpes simplex virus type 2 antibodies in commercial sex workers in Yunnan province, China. Clin Vaccine Immunol 2008 15 : 1301 3.
30. Baines JD, Hsieh CE, Wills E, Mannella C, Marko M. Electron tomography of nascent herpes simplex virus virions. J Virol 2007 81 : 2726 35.
31. Gill N, Ashkar AA. Overexpression of interleukin-15 compromises CD4-dependent adaptive immune responses against herpes simplex virus 2. J Virol 2009 83 : 918 26.